Early-Phase Trial Shows Venetoclax Plus HMA Has High Response Rates in Older Patients With AML

Press/Media: Press / Media

PeriodDec 1 2018

Media coverage

1

Media coverage

  • TitleEarly-Phase Trial Shows Venetoclax Plus HMA Has High Response Rates in Older Patients With AML
    Media name/outletASH Clinical News
    CountryUnited States
    Date12/1/18
    PersonsRobert A Hromas